<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2023;13(4): 289-300. doi: 10.34172/bi.2022.24132
PMID: 37645025        PMCID: PMC10460769

Original Research

Differentiation and molecular characterization of endothelial progenitor and vascular smooth muscle cells from induced pluripotent stem cells

Mohammadreza Dastouri 1 * ORCID, Hilal Ozdag 1 ORCID, Ahmet Ruchan Akar 2 ORCID, Alp Can 3 ORCID

Cited by CrossRef: 3

1- Sanli B, Dastouri M. Regenerative medicine and congenital heart diseases: Current approaches and future directions. Biomed adv. 2024;1(1):2 [Crossref]
2- Shen S, Pan T, Liu P, Tian Y, Shi Y, Zhu W. The mechanisms and applications of endothelial progenitor cell therapy in the treatment of intracranial aneurysm. J Transl Med. 2025;23(1) [Crossref]
3- Cheng J, Cook A, Talbot J, Perry S. How is Excitotoxicity Being Modelled in iPSC-Derived Neurons?. Neurotox Res. 2024;42(5) [Crossref]
4- Wang S, Zhong H, Wu Y, Zhang Y, Sha A, Zhu Z, Fang X, Bao M, Sun D. Advances in the differentiation of induced pluripotent stem cells into vascular cells for the treatment of diabetic microvascular disease. Cardiovasc Diabetol. 2026; [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons